市场调查报告书
商品编码
1355823
灌注系统市场 - 按技术(低温机器灌注、常温机器灌注)、按组件(制氧机、心肺机、灌注泵、监测系统)、按应用、按最终用途和预测,2023 - 2032 年Perfusion Systems Market - By Technique (Hypothermic Machine Perfusion, Normothermic Machine Perfusion), By Component (Oxygenators, Heart-Lung Machine, Perfusion Pumps, Monitoring System), By Application, By End-use & Forecast, 2023 - 2032 |
2023 年至 2032 年间,全球灌注系统市场的复合年增长率将达到 4.6%。心血管和呼吸系统疾病的盛行率不断增加,器官移植和手术需要先进的灌注系统。医疗技术的进步带来了更复杂和高效的灌注系统。 FDA 对涉及大量或与之相关的最新技术设备的批准不断增加,支持了市场的成长。
例如,2023 年 8 月,领先的医疗技术公司 LivaNova PLC 宣布其 Essenz (TM) 线上血液监测仪 (ILBM) 获得 FDA 和 CE 标誌的监管许可。此监视器整合到 Essenz (TM) 灌注系统中,使灌注师能够从系统的驾驶舱方便地存取和管理血液参数,无需额外的监视器或支架。人口老化的加剧增加了器官移植的需求,进一步推动了市场的成长。此外,人们日益认识到灌注在医疗保健中的重要性以及全球器官移植计划的扩展推动了灌注系统的市场前景。
整个灌注系统市场根据技术、应用和区域进行分类。
常温机器灌注领域将在 2023 年至 2032 年期间经历重大发展。这种先进技术在移植过程中在接近正常体温的情况下保存和评估器官,从而增强其活力和功能。常温机器灌注在移植手术中变得越来越重要,因为它可以更好地评估器官并延长成功移植的时间窗口,从而推动此类系统对灌注系统市场收入的贡献。
细胞灌注系统部分从 2023 年到 2032 年将实现值得称讚的复合年增长率。这些专用设备在细胞培养和组织工程应用中至关重要,为培养细胞和组织提供受控环境。研究人员和生物技术人员依靠细胞灌注系统来复製生理条件、研究细胞行为并开发先进的疗法。对精确、高效的细胞灌注技术的需求持续推动灌注系统市场的成长。
欧洲灌注系统产业从 2023 年到 2032 年将呈现可观的复合年增长率。该地区完善的医疗基础设施和越来越多的器官移植手术推动了对先进灌注系统的需求。常温机器灌注和创新技术在欧洲医疗保健领域日益受到重视,进一步促进了市场成长。由于专注于改善移植结果和解决器官短缺问题,欧洲仍然是医疗领域灌注系统的关键市场。
Global Perfusion Systems Market will witness 4.6% CAGR between 2023 and 2032. The increasing prevalence of cardiovascular and respiratory diseases necessitates advanced perfusion systems for organ transplants and surgeries. Advancements in medical technology have led to more sophisticated and efficient perfusion systems. Rising FDA approvals for the latest technological devices involving or associated with profusions support market growth.
For instance, in August 2023, LivaNova PLC, a leading medical technology company, announced the attainment of regulatory clearances from the FDA and CE Mark for its Essenz™ In-Line Blood Monitor (ILBM). Integrated into the Essenz™ Perfusion System, the monitor enables perfusionists to access and manage blood parameters conveniently from the system's cockpit, eliminating the need for extra monitors or holders. The rising aging population contributes to the demand for organ transplantation, further fueling market growth. Additionally, the growing awareness of the importance of perfusion in healthcare and the expansion of organ transplant programs globally drive the perfusion systems market outlook.
The overall Perfusion Systems Market is classified based on technique, application, and region.
The normothermic machine perfusion segment will undergo significant development from 2023 to 2032. This advanced technique preserves and evaluates organs at near-normal body temperatures during transplantation, enhancing their viability and functionality. Normothermic machine perfusion is becoming increasingly crucial in transplant procedures, as it allows for better organ assessment and extends the window of time for successful transplantation, driving the contribution of such systems in the perfusion systems market revenue.
The cell perfusion system segment will register a commendable CAGR from 2023 to 2032. These specialized devices are vital in cell culture and tissue engineering applications, providing a controlled environment for nurturing cells and tissues. Researchers and biotechnologists rely on cell perfusion systems to replicate physiological conditions, study cell behavior, and develop advanced therapies. The demand for precise and efficient cell perfusion technology continues to drive the perfusion systems market growth.
Europe Perfusion Systems Industry will showcase an appreciable CAGR from 2023 to 2032. The region's well-established healthcare infrastructure and a growing number of organ transplant procedures drive the need for advanced perfusion systems. Normothermic machine perfusion and innovative technologies are gaining prominence in European healthcare, further contributing to market growth. With a focus on improving transplant outcomes and addressing organ shortages, Europe remains a pivotal market for perfusion systems in the medical field.